Theranos’ Holmes says investors were future-focused as testimony wraps

Published by

By Jody Godoy SAN JOSE, Calif. (Reuters) – Theranos founder Elizabeth Holmes finished testifying in her own defense against fraud charges on Wednesday morning, telling jurors that investors “weren’t interested in today” but focused on the blood-testing startup’s impact in the long-run. Holmes, 37, faces nine counts of fraud and two counts of conspiracy for allegedly lying about Theranos’ technology to bring in cash from wealthy private investors and patients who paid for tests from the company. Holmes rose to fame in Silicon Valley for her ambitious play to reinvent blood testing with a device…

Read More

Leave a Reply